SANDRA EHRLER: Open Payments
NPI 1235773185 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 54 payments from 17 companies in 2025. Trend: 2023 $976 · 2024 $923 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $234 |
| PFIZER INC. | 6 | $119 |
| Janssen Biotech, Inc. | 4 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $98 |
| Madrigal Pharmaceuticals | 3 | $78 |
| Ardelyx, Inc. | 3 | $72 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Lilly USA, LLC | 2 | $49 |
| QOL Medical, LLC | 1 | $27 |
Products named: SKYRIZI, TREMFYA, REZDIFFRA, IBSRELA, VELSIPITY, IQIRVO, ENTYVIO, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
